Cite
HARVARD Citation
Tanida, S. et al. (2018). Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease. Therapeutic apheresis and dialysis. 22 (3), pp. 295-300. [Online].